Lanxess (LXS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Meeting opened with acknowledgment of the challenging environment for the European chemical industry, emphasizing the need for proactive internal measures.
Financial performance review
Group sales in 2025 were EUR 5.7 billion, an 11% decline from the previous year.
EBITDA pre exceptionals fell by 17% to EUR 510 million, mainly due to weak demand and divestments.
Net financial debt reduced to around EUR 2 billion, nearly 50% less than in 2022.
Cash reserves at year-end were about EUR 500 million, with undrawn credit lines of EUR 1.4 billion.
Dividend announcements
Proposal for a stable dividend of EUR 0.10 per share, totaling approximately EUR 9 million, signaling continuity and financial restraint.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Lanxess
- Q3 earnings and free cash flow improved; FY guidance targets the range’s upper end.LXS
Q3 2026 (Media) - Pricing lifted Q3 EBITDA 11.2%; FY guidance targets the range’s upper end.LXS
Q3 2026 - Q2 2026 saw strong sales and EBITDA growth, positive cash flow, and guidance reaffirmed.LXS
Q2 2026 (Media) - Q2 2026 delivered higher sales, strong EBITDA, and positive cash flow, but net income stayed negative.LXS
Q2 2026 - Sales and EBITDA fell sharply, but full-year guidance is maintained amid persistent market headwinds.LXS
Q1 2026 (Media) - Sales and EBITDA dropped, but full-year guidance is confirmed and Q2 is set to improve.LXS
Q1 2026 - Sales and EBITDA fell, debt reduced, and EUR 100M cost savings with 550 job cuts announced.LXS
Q4 2025 (Media) - Sales and EBITDA fell sharply in Q3 2025, with cost actions and divestments improving leverage.LXS
Q3 2025 - EBITDA pre rose 32% to €133m, guidance held, and Urethane sale proceeds to reduce debt.LXS
Q1 2025